Neuren Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Sep 23 | BuyUS$38,551 | Joe Basile | Individual | 5,000 | US$7.71 | |
14 Jun 23 | SellUS$10,435,169 | Trevor Scott | Individual | 1,175,000 | US$8.88 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 404,072 | 0.316% |
Individual Insiders | 4,223,925 | 3.31% |
Private Companies | 13,859,012 | 10.9% |
Institutions | 22,058,141 | 17.3% |
General Public | 87,150,526 | 68.2% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,561,977 | US$90.1m | 0% | 1.97% | |||
5,008,265 | US$68.8m | 0.24% | no data | |||
4,123,084 | US$56.6m | -1.98% | no data | |||
3,014,397 | US$41.4m | 0% | no data | |||
2,705,643 | US$37.1m | 0% | 1.84% | |||
2,633,787 | US$36.2m | 7.06% | no data | |||
2,414,784 | US$33.2m | 0% | no data | |||
2,208,711 | US$30.3m | -0.2% | no data | |||
1,870,000 | US$25.7m | -6.97% | no data | |||
1,761,385 | US$24.2m | -6.56% | no data | |||
1,500,000 | US$20.6m | 0% | no data | |||
750,000 | US$10.3m | 0% | no data | |||
750,000 | US$10.3m | -5.06% | no data | |||
707,030 | US$9.7m | -2.56% | 0.07% | |||
671,637 | US$9.2m | 0% | no data | |||
470,756 | US$6.5m | -1.23% | no data | |||
421,309 | US$5.8m | 0% | 0.07% | |||
415,760 | US$5.7m | -0.24% | no data | |||
405,000 | US$5.6m | -26.4% | no data | |||
404,072 | US$5.5m | 0% | no data | |||
398,207 | US$5.5m | 0% | no data | |||
264,634 | US$3.6m | 0% | no data | |||
208,781 | US$2.9m | 0.17% | no data | |||
86,525 | US$1.2m | 31.6% | no data | |||
85,378 | US$1.2m | 0% | no data |